Lercanidipinhydrochlorid Sandoz

Lercanidipine Hydrochloride, the active ingredient in Lercanidipinhydrochlorid Sandoz, is a calcium‑channel blocker presented as a tablet for oral use. It is used to treat hypertension in adult patients. GNH USA supplies Lercanidipinhydrochlorid Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Lercanidipinhydrochlorid Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Lercanidipine hydrochloride is indicated for the management of high blood pressure, acting on the vascular smooth muscle to lower systemic resistance.

- Hypertension: Reduces systolic and diastolic blood pressure to target levels. - Chronic stable angina (off‑label): May improve exercise tolerance by reducing cardiac workload. - Peripheral arterial disease (off‑label): May aid in improving blood flow through vasodilation. - Post‑myocardial infarction (off‑label): Supports blood pressure control in recovery phase. - Renal impairment associated hypertension (off‑label): Assists in managing blood pressure when kidney function is reduced.

Lercanidipine hydrochloride may cause a range of adverse reactions, most of which are mild to moderate in severity.

Common Side Effects: - Headache - Flushing - Peripheral edema - Dizziness - Tired  - Nasal congestion

Serious or Rare Side Effects: - Severe hypotension - Acute myocardial infarction - Atrioventricular block - Hepatotoxic  - Stevens‑  -                                """"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""